Effect of Combine Therapy by Mometasone Furoate and Azelastine with Single Therapy by Mometazone Furoate or Azelastine on Adenoid Size and Obstructive Symptoms in Patients Referring to ENT Clinic

Phase 3

Recruiting

• Conditions: Obstruction Symptoms and Size of Adenoid.

• Registration Number: IRCT20200612047740N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

6 to 12 Years old
Children With Hypertrophy of Adenoid Grade 3 and 4 According to Cassano Grading

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Obstructive Sleep Apnea. Timepoint: At the Beginning and End of 30 Days Treatment Duration. Method of measurement: Berlucchi Grading.;Night Snoring. Timepoint: At the Beginning and End of 30 Days Treatment Duration. Method of measurement: Berlucchi Grading.;Cough. Timepoint: At the Beginning and End of 30 Days Treatment Duration. Method of measurement: Berlucchi Grading.;Rhinorrhea. Timepoint: At the Beginning and End of 30 Days Treatment Duration. Method of measurement: Berlucchi Grading.;Nasal obstruction. Timepoint: At the Beginning and End of 30 Days Treatment Duration. Method of measurement: Berlucchi Grading.;Adenoid size/nasopharyngeal depth ratio. Timepoint: At the Beginning and End of 30 Days Treatment Duration. Method of measurement: Lateral Nasopharynx Radiography.